Cargando…
Protocol for randomized controlled trial to evaluate the safety and feasibility of a novel helmet to deliver transcranial light emitting diodes photobiomodulation therapy to patients with Parkinson’s disease
INTRODUCTION: Parkinson’s disease (PD) is the second most common, progressive, and debilitating neurodegenerative disease associated with aging and the most common movement disorder. Photobiomodulation (PBM), the use of non-thermal light for therapeutic purposes using laser or light emitting diodes...
Autores principales: | McGee, Claire, Liebert, Ann, Herkes, Geoffrey, Bicknell, Brian, Pang, Vincent, McLachlan, Craig S., Kiat, Hosen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428720/ https://www.ncbi.nlm.nih.gov/pubmed/36061601 http://dx.doi.org/10.3389/fnins.2022.945796 |
Ejemplares similares
-
A Randomized Placebo-Controlled Study of a Transcranial Photobiomodulation Helmet in Parkinson’s Disease: Post-Hoc Analysis of Motor Outcomes
por: McGee, Claire, et al.
Publicado: (2023) -
Microbiome Changes in Humans with Parkinson’s Disease after Photobiomodulation Therapy: A Retrospective Study
por: Bicknell, Brian, et al.
Publicado: (2022) -
Photophysical Mechanisms of Photobiomodulation Therapy as Precision Medicine
por: Liebert, Ann, et al.
Publicado: (2023) -
Neurodegenerative and Neurodevelopmental Diseases and the Gut-Brain Axis: The Potential of Therapeutic Targeting of the Microbiome
por: Bicknell, Brian, et al.
Publicado: (2023) -
A Potential Role for Photobiomodulation Therapy in Disease Treatment and Prevention in the Era of COVID-19
por: Liebert, Ann, et al.
Publicado: (2020)